DOI QR코드

DOI QR Code

Acute Toxicity Study of the Glyoxal by Intratracheal Instillation in Male Sprague-Dawley Rats

수컷 랫드(Sprague-Dawley)에서 글리옥살(glyoxal)의 단회 기도내 투여에 따른 급성 독성시험

  • Kim, Hyeon-Young (National Center for Efficacy Evaluation of Respiratory Disease Product, Korea Institute of Toxicology) ;
  • Kim, Kicheon (National Center for Efficacy Evaluation of Respiratory Disease Product, Korea Institute of Toxicology) ;
  • Kim, In-Hyeon (National Center for Efficacy Evaluation of Respiratory Disease Product, Korea Institute of Toxicology) ;
  • Kim, Min-Seok (National Center for Efficacy Evaluation of Respiratory Disease Product, Korea Institute of Toxicology) ;
  • Kim, Sung-Hwan (National Center for Efficacy Evaluation of Respiratory Disease Product, Korea Institute of Toxicology) ;
  • Lee, Kyuhong (National Center for Efficacy Evaluation of Respiratory Disease Product, Korea Institute of Toxicology)
  • Received : 2019.09.10
  • Accepted : 2019.11.05
  • Published : 2019.12.31

Abstract

Objectives: The present study was performed to obtain acute toxicity information on glyoxal in male rats after intratracheal instillation. Methods: In order to calculate the LD50 of glyoxal using Probit analysis with SAS, the test article was one intratracheal instillation to male Sprague-Dawley rats at dose levels of 0, 225, 451 or 902 mg/kg. During the test period, mortality, clinical signs, and body and organ weights were examined. At the end of the 14-day observation period, all animals were sacrificed and complete gross postmortem and histopathological examinations were performed. Results: Four animals of the 902 mg/kg group died within one week after the administration of glyoxal. All treatment group in a dose dependent manner, decreased body weight was found during the study period. The absolute and relative lung weight, and histopathological changes (bronchiolar-alveolar hyperplasia, chronic inflammation) of lung exhibited an increased in glyoxal treated groups in a dose dependent manner. However, there were no changes on the organ weights and histopathological changes of any other organ except lung. Conclusions: The results obtained in the present study suggest that the LD50 in male Sprague-Dawley rats after a single intratracheal instillation of glyoxal was considered to be 866.9 mg/kg and the lung was found to be the target organ for glyoxal.

Keywords

References

  1. Alexander DJ, Collins CJ, Coombs DW, Gilkison IS, Hardy CJ, Healey G, Karantabias G, Johnson N, Karlsson A, Kilgour JD, McDonald P. Association of inhalation toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol 2008;20(13):1179-1189 https://doi.org/10.1080/08958370802207318
  2. Andersen H, Larsen S, Spliid H, Christensen ND. Multivariate statistical analysis of organ weights in toxicity studies. Toxicology 1999;136(2-3):67-77 https://doi.org/10.1016/S0300-483X(99)00056-6
  3. Bailey SA, Zidell RH, Perry RW. Relationship between organ weight and body/brain weight in the rat: what is the best analytical end point? Toxicol Pathol 2004;32(4):448-466 https://doi.org/10.1080/01926230490465874
  4. Grosjean D. Particulate carbon in Los Angeles air. Sci Total Environ 1984;32:133-145 https://doi.org/10.1016/0048-9697(84)90126-8
  5. Ho SSH, Yu JZ. Feasibility of collection and analysis of airborne carbonyls by on-sorbent derivatization and thermal desorption. Anal Chem 2002;74(6):1232-1240 https://doi.org/10.1021/ac015708q
  6. Hoechst AG. Glyoxal 40N. Akute Aerosolinhalation an männlichen und weiblichen SPF-Wistar-Ratten. 4 Stunden -LC50. Frankfurt, Hoechst AG, pp. 1-7 (Report No. 84.0378;NTIS/OTS 0535127; EPA/OTS86-920000799), 1984
  7. Hoechst AG. Glyoxal 40% (aqueous solution) - testing for subacute (29-days) inhalation toxicity in male and female Wistar rats. Frankfurt, Hoechst AG, Pharma Development, Corporate Toxicology (Unpublished Report No. 94.1056), 1995
  8. Kim JC, Kim SH, Shin DH, Ahn TH, Kim HC, Kim YB, Jiang CZ, Han J, Chung MK. Effects of prenatal exposure to the environmental pollutant 2- bromopropane on embryo-fetal development in rats. Toxicology 2004a;196(1-2):77-86 https://doi.org/10.1016/j.tox.2003.11.006
  9. Kim JC, Shin DH, Kim SH, Kim JK, Park SC, Son WC, Lee HS, Suh JE, Kim CY, Ha CS, Chung MK. Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats. Regul Toxicol Pharmacol 2004b;40(3):356-369 https://doi.org/10.1016/j.yrtph.2004.09.002
  10. Kim MS, Kim SH, Jeon D, Kim HY, Lee K. Changes in expression of cytokines in polyhexamethylene guanidine induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis. Toxicology 2018a;393:185-192 https://doi.org/10.1016/j.tox.2017.11.017
  11. Kim MS, Kim SH, Jeon D, Kim HY, Han JY, Kim B, Lee K. Low-dose cadmium exposure exacerbates polyhexamethylene guanidine-induced lung fibrosis in mice. J Toxicol Environ Health A 2018b;81(11):384-396 https://doi.org/10.1080/15287394.2018.1451177
  12. Kim HY, Kim MS, Kim SH, Jeon D, Lee K. Protective Effects of Nintedanib against Polyhexamethylene Guanidine Phosphate-Induced Lung Fibrosis in Mice. Molecules 2018c;7:23(8). E1974
  13. Kim MS, Han JY, Kim SH, Jeon D, Kim HY, Lee SW, Rho MC, Lee K. Oleanolic acid acetate attenuates polyhexamethylene guanidine phosphate-induced pulmonary inflammation and fibrosis in mice. Respir Physiol Neurobiol 2018d;252-253:1-9 https://doi.org/10.1016/j.resp.2018.03.001
  14. Korea Occupational Safety and Health Agency (KOSHA), http://www.kosha.or.kr/
  15. McDonald JD, Zielinska B, Fujita EM, Sagebiel JC, Chow JC et al. Fine particle and gaseous emission rates from residential wood combustion. Environ Sci Technol 2000;34(11):2080-2091 https://doi.org/10.1021/es9909632
  16. Mellon Institute Special report. Results of feeding glyoxal in the diet of rats and of dogs for three months. Pittsburgh, PA, University of Pittsburgh, Mellon Institute of Industrial Research 1966;1-20 (Report 29-1; NTIS/OTS 852-5072)
  17. Moree-Testa P, Saint-Jalm Y. Determination of ${\alpha}$-dicarbonyl compounds in cigarette smoke. J Chromatogr A 1981;217:197-218 https://doi.org/10.1016/s0021-9673(00)88074-7
  18. O'Brien PJ, Siraki AG, Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 2005;35(7):609-662 https://doi.org/10.1080/10408440591002183
  19. Oberdorster G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Toxicol 1996;8(suppl):73-89
  20. Risk Policy Analysts (RPA). Study on Specific Needs for Information on the Content of Dangerous Substances in Construction Products; Final Report Prepared for DG Enterprise & Industry; RPA: Norfolk, UK, 2013
  21. Scientific Committee on Consumer Products (SCCP). Opinion on: Glyoxal (SCCP/0881/05) Adopted by the SCCP during the 4th Plenary of 21 June 2005; SCCP:Luxembourg, 2005
  22. Shangari N, Bruce WR, Poon R, O'Brien PJ. Toxicity of glyoxals-role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochem Soc Trans 2003;31(Part 6):1390-1393 https://doi.org/10.1042/bst0311390
  23. Shangari N, O'Brien PJ. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem Pharmacol 2004;68(7):1433-1442 https://doi.org/10.1016/j.bcp.2004.06.013
  24. Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 2014;18:1-14 https://doi.org/10.4196/kjpp.2014.18.1.1
  25. Societe Francaise Hoechst. Glyoxal 40. 28 day dose range finding study in rats by administration in drinking water. Unpublished report (Study No. 2619 TSR;HOE 87.1678) 1987 [cited in BUA, 1997]
  26. Takahashi M, Okamiya H, Furukawa F, Toyoda K, Sato H, Imaida K, Hayashi Y, Effects of glyoxal and methylglyoxal administration on gastric carcinogenesis in Wistar rats after initiation with N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 1989;10(10):1925-1927 https://doi.org/10.1093/carcin/10.10.1925
  27. World Health Organization (WHO). Concise International Chemical Assessment Document 57: Glyoxal. International Programme on Chemical Safety II; World Health Organization: Geneva, Switzerland, 2004